What We're Reading: Page 114
Industry reads hand-picked by our editors
Jun 15, 2022
-
FierceBiotech
BIO'22 marked by first-time handshakes and attempts at survival
-
The Atlantic
Monkeypox Vaccines Are Too Gnarly for the Masses
-
Financial Times
Investors bet on AI start-ups to turbocharge drug development
-
Associated Press
FDA advisers back Moderna's COVID-19 vaccine for older kids
Jun 14, 2022
-
Financial Times
BioNTech’s second act: can it transform the fight against cancer?
-
The Wall Street Journal
Lawmakers Make Bipartisan Push for New Government Powers to Block U.S. Investments in China
-
Fierce Biotech
Blade Therapeutics' SPAC merger is cancelled
-
San Francisco Business Times
Biotech industry pushes Congress to allow new incentive to help capital-hungry startups
Jun 13, 2022
Jun 10, 2022
Jun 09, 2022
Jun 08, 2022
-
MIT Technology Review
Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging
-
Science
As monkeypox threat grows, scientists debate best vaccine strategy
-
Fierce Pharma
Sanofi moves into big Cambridge HQ, where 2,500 will work
-
JAMA
Trends in Prescription Drug Launch Prices, 2008-2021
Previous
